《Drug Resistance in the Treatment of Cancer》是一本圖書,作者是Pinedo, Herbert M.; Giaccone, Giuseppe; Sikora, Karol
基本介紹
- ISBN:9780521473217
- 作者:Pinedo, Herbert M.; Giaccone, Giuseppe; Sikora, Karol
- 出版時間:1998年3月
- 頁數:339
- 定價:$ 248.60

《Drug Resistance in the Treatment of Cancer》是一本圖書,作者是Pinedo, Herbert M.; Giaccone, Giuseppe; Sikora, Karol
《Drug Resistance in the Treatment of Cancer》是一本圖書,作者是Pinedo, Herbert M.; Giaccone, Giuseppe; Herbert M., Pinedo 內容簡介 The development of drug-resistant cancers is considered to be the most significant ...
When this volume was first published in 1998, drug resistance in cancer, whereby a proportion of cancer cells evades chemotherapy, poses a profound and continuing challenge for the effective treatment of cancer. The ...
is not a single drug available that is 100% effective against metastatic cancer. Resistance to treatment with anticancer drugs results from a variety of factors including indiv...(展開全部) The inability of cancer drug...
《Multiple Drug Resistance in Cancer》是一本圖書,作者是Clynes, Manfred 內容簡介 Resistance to chemotherapy, and especially multi-drug resistance, represents a significant barrier to the successful treatment of cancer. This ...
immunotherapy, drug resistance gene therapy, and the genetic modification of stem cells. Researchers at all levels of develo...(展開全部) The third edition of Gene Therapy of Cancer provides crucial updates on the basic...
《Drug Resistance》是一本圖書,作者是Hait, William N.內容簡介 Resistance to treatment represents the final common outcome for far too many patients with cancer. Even our most promising new drugs fall victim to drug ...
16. Cetuximab-modified mesoporous silica nano-medicine specifically targets EGFR-mutant lung cancer and overcomes drug resistance - PubMed .National Library of Medicine[引用日期2021-03-09] 17. Mesoporous Nanoparticles: Gated Me...
Nanoscale drug delivery for taxanes based on the mechanism of multidrug resistance of cancer.Biotechnol Adv.2015 Jan-Feb;33(1):224-41.(SCI IF: 9.848) 27.Gong LH, Chen XX, Pan SS, Qiu JG, Mei XL, Jiang QW, ...
Clinical efficacy and safety of afatinib in the treatment of non-small-cell lung cancer in Chinese patients. [J]. Onco Targets Ther, 11: 529-538 [4] Shi YX, Wang Y, Li X, Zhang W, Zhou HH, Yin JY#, Liu ...
